Back to Agenda
Session 12: Future Direction of Drug Safety/Risk Communication
Session Chair(s)
Nancy D. Smith, PhD
Adjunct Professor
Temple University, FDA Alumni, United States
In this session we will discuss the FDA’s efforts to improve understanding of the risks and benefits of regulated products, and good examples from Industry and other sources.
- New FDA Communication Guidance Documents
Have an account?